ANDRÉS JESÚS
MUÑOZ MARTÍN
Profesor asociado


Hospital Universitario Central de Asturias
Oviedo, EspañaPublications in collaboration with researchers from Hospital Universitario Central de Asturias (11)
2024
2023
2022
-
Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence
European Journal of Internal Medicine, Vol. 100, pp. 33-45
-
Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial
Thrombosis and haemostasis, Vol. 122, Núm. 10, pp. 1653-1661
-
Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis
European Journal of Internal Medicine, Vol. 105, pp. 30-37
2021
-
Early clinical experience with trifluridine/tipiracil for refractory metastatic colorectal cancer: The ros study
Cancers, Vol. 13, Núm. 18
-
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis
Drugs and Aging, Vol. 38, Núm. 3, pp. 219-231
2020
-
A snapshot of cancer-associated thromboembolic disease in 2018–2019: First data from the TESEO prospective registry
European Journal of Internal Medicine, Vol. 78, pp. 41-49
2018
2017
-
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain
Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 667-681
2016
-
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
British Journal of Cancer, Vol. 115, Núm. 7, pp. 789-796